Publicis acquires health analytics firm Verilogue
pharmafile | December 10, 2013 | News story | Medical Communications | Publicis Groupe, Veriogue, agency, comms
Publicis Groupe has acquired Verilogue, a healthcare analytics firm that specialises in doctor-patient communication.
The US, Pennsylvania-based agency will now become part of Publicis Healthcare Communications, which has offices around the world.
Founded in 2006 Verilogue specialises in “the worldwide digital capture and linguistic analysis of real-world encounters between physicians, nurses, patients, and caregivers in North America, Europe, and Asia”, Publicis said in a statement.
Edison Venture Fund, Verilogue’s primary investor, will exit the company as a result of the deal.
Chief executive and co-founder Jeff Kozloff will continue to lead the agency and its 31 staffers. The firm will report to Janet Winkler, president of Publicis Healthcare unit In-Sync Group.
Nick Colucci, president and chief executive of Publicis Groupe, said: “Multichannel influences are creating profound challenges in the physician-patient dialogue. That’s where Verilogue really brings a unique offering to our clients – guiding healthcare communications that are grounded in the voice of the customer.”
Colucci continued: “We were attracted to Verilogue because of their impressive track record and potential for growth when combined with the resources of our global network.”
Kozloff added: “The greatest advances in healthcare delivery over the next decade will be driven by evidence-based solutions delivered at various points-of-care. Aligning ourselves with PHCG’s market-leading agencies and impressive talent and resources allows us to enter a new chapter.
“We will be able to immediately expand our global presence and transform our insights engine into solutions, driving client value through improved customer experiences.”
Related Content
Apiary invests in life sciences SEO pioneer PIO to support global expansion
Private equity firm Apiary Capital has invested in performance-io (PIO), a specialist life sciences performance …
New support guidelines for NHS whistleblowers
New guidelines to support NHS whistleblowers have been proposed by Sir Robert Francis QC – …
No silver bullet, but a growing arsenal for pharma comms
Digital strategies in the pharma industry have predominately been a red herring, focussing too much …
